Rawad Abou Zahr

Urologist @CHIREC Brussels,
former Assistant spécialiste en Urologie @ClinUnivStLuc, former fellow in Robotic and MIS @UROSUD1

[francois rozet @rozetfrancois]

2years of ADT after radical prostatectomy for high Risk #prostate #cancer patients did not improve MFS in phase III RCT AFU-GETUG 20 trial. #GU25
Need to identify better biomarkers of relapse @AFUrologie @GETUG_Unicancer @delataillealex @MRoupret @GPloussard

[Toni Choueiri, MD @DrChoueiri]

IT IS THIS TIME OF THE YEAR AGAIN!

TOP 10 GU Bladder/Kidney Cancer TRIALS FOR 2024

1/ Enfortumab Vedotin (EV) + Pembrolizumab new SOC for patients with metastatic #UC. Trial #EV302 displaced 30y Platinum-based combos
⏩ PFS benefit: 12.5 vs 6.3 mo (HR= 0.45)
⏩ OS benefit: 31.5 vs 16.1 mo (HR= 0.47)

@tompowles1 @NEJM #ESMO2023 Plenary

https://t.co/rv2QsoQf4J

[Rawad Abou Zahr @Rawad_AZ]

@trwherrmann May he rest in peace🙏🏻

[Romain Diamand @RomDiamand]

👏 @GuenzelKarsten @GeorgesMjaess @oderdam @GPloussard @Rochejeanbapti2 @GaelleFiard @Rawad_AZ @PeltierAlexand8 @ThRoumeguere @AnractJulien @GregAssenmacher @pr_gfournier

[Romain Diamand @RomDiamand]

🔥 The added-value of side-specific systematic bx in patients diagnosed by #MRI-targeted bx @EurUrolOncol

🇪🇺 Huge congratulations to the remarkable European team and my fellow researchers for their relentless efforts!

@JulesBordet @sb_uro @Uroweb

https://t.co/XUsQwP4jf9

[Rawad Abou Zahr @Rawad_AZ]

@RomDiamand @ULBruxelles @JulesBordet @PeltierAlexand8 @ThRoumeguere @albisinnidoc Congratulations @RomDiamand !🎉🎉

[Romain Diamand @RomDiamand]

🔥Delighted to share our paper @JulesBordet x @AuroreMattlet on #BCR after #HIFU for #ProstateCancer

📝Using Huber criteria, the 5-y need for 🆕 treatment and failure-free survival were 89% and 98% 🆚 26% and 49%

@PeltierAlexand8 @Rawad_AZ @FouadAoun6

https://t.co/3I44uJdL6F

[European Association of Urology (EAU) @Uroweb]

🆕 Clinical trials have shown a promising role for Botulinum Neurotoxin A in treatment of patients who are non-responders to well-established #erectiledysfunction therapies. Larger trials needed to confirm the findings and define the efficacy and safety of BoNT-A . #EAUguidelines

[Rawad Abou Zahr @Rawad_AZ]

Thanks to the amazing OR and anesthesia teams for their patience and support. I also want to thank @RamsaySante for supporting this program. And finally I want to thank my friends and co-fellows @UroTouzani and Bogdan and wish the best of luck to @ClaudiaKesch and Giorgio. 4/4

[Rawad Abou Zahr @Rawad_AZ]

Bittersweet feeling as I finished my clinical fellowship in Robotics and MIS at @UROSUD1
I'm happy and excited to be starting the next chapter of my career but also sad leave this amazing team who I had the the chance and opportunity to work and learn from. 1/n

[Rawad Abou Zahr @Rawad_AZ]

Thank you @GPloussard for this great opportunity. Thank you Dr Tollon, Dr Loison, @jbbeauval , @dr_almeras_uro , @AmbroiseSalin , @BenjaminPradere, @MarineLesourd for all your selfless guidance, motivation and trust! 3/n

[Rawad Abou Zahr @Rawad_AZ]

@GPloussard @UroTouzani @UROSUD1 Best of luck @UroTouzani , it was a pleasure to work with you!

[Jb Beauval @jbbeauval]

@FocusMeeting salvage prostatectomy is feasible : tips from @RomDiamand ! Bravo @piet_ost @PaulSargos @MRoumiguie @GPloussard @PignotG

[Ploussard Guillaume @GPloussard]

Lymph node dissection in penile cancer: amazing state-of-the-art by Pr Peltier. BAU on stage #FOCUS22 ⁦@ThRoumeguere⁩ ⁦@RomDiamand⁩ ⁦@albisinnidoc⁩

[Rawad Abou Zahr @Rawad_AZ]

@chalhoub_khalil @aklbernard @drelkhoury

[Rawad Abou Zahr @Rawad_AZ]

ICS 2022 Abstract #416 Intracavernosal injection of botulinum toxin in the https://t.co/52CCdqHnMi via @ICSoffice

Best in category prize 🏆
@BoukheirG @gmjaess @teddy_jabbour @chalhoub_khalil @RomDiamand @ThRoumeguere

[Romain Diamand @RomDiamand]

🎯 Perilesional [10mm] and MRI-targeted biopsy reduce the risk of upgrading at #prostatectomy @JulesBordet @KoelisBx

🧠 @PeltierAlexand8 @Rawad_AZ @AuroreMattlet @albisinnidoc @ThRoumeguere

👇 https://t.co/lIlNcseTn7

[Romain Diamand @RomDiamand]

Robotic Partial Cystectomy for Urachal Carcinoma: A Case Report and Review of the Literature

@Rawad_AZ @valclnt @AuroreMattlet

👇 https://t.co/sVBmzv6TL4

[AFUF @afufuro]

✨Le jeune urologue et le cancer de prostate hormonorésistant : que doit-il savoir ? Merci au Dr Grossgoupil, oncologue, pour cette présentation interactive. ✨ En direct sur https://t.co/lYv5NEMVF1